These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 16124994)
1. Prolactin and growth hormone signaling. Chilton BS; Hewetson A Curr Top Dev Biol; 2005; 68():1-23. PubMed ID: 16124994 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat. Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520 [TBL] [Abstract][Full Text] [Related]
4. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161 [TBL] [Abstract][Full Text] [Related]
5. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter. Selvaraj NG; Omi E; Gibori G; Rao MC Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534 [TBL] [Abstract][Full Text] [Related]
6. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans. Brelje TC; Stout LE; Bhagroo NV; Sorenson RL Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985 [TBL] [Abstract][Full Text] [Related]
7. The prolactin/growth hormone receptor family: structure/function relationships. Goffin V; Kelly PA J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):7-17. PubMed ID: 10887515 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells. Morales O; Lindgren U; Haldosén LA J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411 [TBL] [Abstract][Full Text] [Related]
9. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice. Miquet JG; Sotelo AI; Bartke A; Turyn D Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541 [TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance. Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Rabkin R; Sun DF; Chen Y; Tan J; Schaefer F Pediatr Nephrol; 2005 Mar; 20(3):313-8. PubMed ID: 15692835 [TBL] [Abstract][Full Text] [Related]
13. Prolactin signals through RUSH/SMARCA3 in the absence of a physical association with Stat5a. Hewetson A; Moore SL; Chilton BS Biol Reprod; 2004 Dec; 71(6):1907-12. PubMed ID: 15306550 [TBL] [Abstract][Full Text] [Related]
14. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911 [TBL] [Abstract][Full Text] [Related]
15. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells. Horsch K; Schaller MD; Hynes NE Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5. Pezet A; Ferrag F; Kelly PA; Edery M J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112 [TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice. Nukaya M; Takahashi Y; Gonzalez FJ; Kamataki T FEBS Lett; 2004 Jan; 558(1-3):96-100. PubMed ID: 14759523 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH), GH receptor, and signal transduction. Kopchick JJ; Andry JM Mol Genet Metab; 2000; 71(1-2):293-314. PubMed ID: 11001823 [No Abstract] [Full Text] [Related]
19. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation. Gebert CA; Park SH; Waxman DJ Mol Endocrinol; 1999 Feb; 13(2):213-27. PubMed ID: 9973252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]